{
    "organizations": [],
    "uuid": "9495ca3ec90b4906655a6b912d1e3740339fdfc8",
    "author": "",
    "url": "https://www.reuters.com/article/brief-therapix-biosciences-says-us-fda-c/brief-therapix-biosciences-says-u-s-fda-cleared-ind-for-thx-110-in-treatment-of-chronic-low-back-pain-idUSFWN1R20JQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Therapix Biosciences Says U.S. FDA Cleared IND For THX-110 In Treatment Of Chronic Low Back Pain",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 20, 2018 / 2:14 PM / Updated 29 minutes ago BRIEF-Therapix Biosciences Says U.S. FDA Cleared IND For THX-110 In Treatment Of Chronic Low Back Pain Reuters Staff March 20 (Reuters) - Therapix Biosciences Ltd: * THERAPIX BIOSCIENCES - U.S. FDA CLEARED IND FOR THX-110 IN TREATMENT OF CHRONIC LOW BACK PAIN * THERAPIX BIOSCIENCES - EXPECTS TO COMMENCE PHASE IIA CLINICAL TRIAL FOR CHRONIC LOW BACK PAIN DRUG DURING Q2 2018 Source text: ( bit.ly/2GMdJ8D ) Further company coverage:",
    "published": "2018-03-20T16:14:00.000+02:00",
    "crawled": "2018-03-20T16:33:41.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "bioscience",
        "say",
        "fda",
        "cleared",
        "ind",
        "treatment",
        "chronic",
        "low",
        "back",
        "pain",
        "reuters",
        "staff",
        "march",
        "reuters",
        "therapix",
        "bioscience",
        "ltd",
        "therapix",
        "bioscience",
        "fda",
        "cleared",
        "ind",
        "treatment",
        "chronic",
        "low",
        "back",
        "pain",
        "therapix",
        "bioscience",
        "expects",
        "commence",
        "phase",
        "iia",
        "clinical",
        "trial",
        "chronic",
        "low",
        "back",
        "pain",
        "drug",
        "q2",
        "source",
        "text",
        "company",
        "coverage"
    ]
}